Edible Yellow Mealworm-Derived Antidiabetic Peptides: Dual Modulation of α-Glucosidase and Dipeptidyl-Peptidase IV Inhibition Revealed by Integrated Proteomics, Bioassays, and Molecular Docking Analysis

Yuying Zhu, Enning Zhou, Yingran Tang, Qiangqiang Li, Liming Wu · 2025

Read Edible Yellow Mealworm-Derived Antidiabetic Peptides: Dual Modulation of α-Glucosidase and Dipeptidyl-Peptidase IV Inhibition Revealed by Integrated Proteomics, Bioassays, and Molecular Docking Analysis by Yuying Zhu, Enning Zhou, Yingran Tang, Qiangqiang Li, Liming Wu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785325.txt.

Description

Mealworms may seem an unlikely source of diabetes drugs, but Yuying Zhu and co-authors mined the yellow mealworm Tenebrio molitor for peptides that fight type 2 diabetes on two fronts. Guided by proteomics, their screening found six peptides that block two enzymes at once: alpha-glucosidase and dipeptidyl-peptidase IV. The peptides also raised glucose uptake in insulin-resistant liver cells.

Docking maps show how the peptides grip each enzyme's active sites through hydrogen bonds and hydrophobic contacts. The team frames insect protein as both a sustainable food resource and a source of candidate therapies. Lab tests so far are early, and animal or human studies would come next.

Catalog record

CREATORYuying Zhu, Enning Zhou, Yingran Tang, Qiangqiang Li, Liming Wu
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12785325

Browse the full library · About the Tower of Babel